We report on the clinical and molecular assessment of FGFR2 in six Apert syndrome patients from six Egyptian families, highlighting the importance of raising awareness about the cardinal phenotype of AS and informing physicians about variability and genetic counseling decisions. The gene discussed is FGFR2; the disease is Apert syndrome.